NIA
ELV icon

Northstar Investment Advisors’s Elevance Health ELV Stock Holding History

Northstar Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3.79M Buy
9,856
+204
+2% +$78K 0.5% 59
2021
Q1 		$3.46M Buy
+9,652
New +$3.1M 0.5% 54

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northstar Investment Advisors's ELV Position: Q2 2021 in Review

Northstar Investment Advisors increased its Elevance Health (ELV) stake by 2.1% in Q2 2021, buying an estimated $78K and bringing the position to 9,856 shares worth $3.79M. The position accounts for 0.5% of the portfolio, ranked #59.

Northstar Investment Advisors first reported a position in ELV in Q1 2021 and has held it in 2 quarters since. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • Northstar Investment Advisors held 9,856 shares of Elevance Health worth $3.79M as of Q2 2021.
  • Northstar Investment Advisors bought 204 Elevance Health shares in Q2 2021, an estimated $78K.
  • Elevance Health made up 0.5% of Northstar Investment Advisors's portfolio in Q2 2021, its #59 holding.
  • Northstar Investment Advisors first reported a position in Elevance Health in Q1 2021 and has held it in 2 quarters since.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Northstar Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.